BONE LIFT 0.5MG TAB 30S
BONE LIFT contains Alfacalcidol, an active form of Vitamin D that helps the body regulate calcium and phosphate metabolism. It is prescribed for certain conditions associated with low calcium levels, impaired bone mineralization and disturbances in Vitamin D metabolism.
BONE-LIFT is commonly listed in Pakistan as Alfacalcidol 0.5mcg, in a 1×30 tablet pack. Please verify the strength on the pack before publishing the product information.
Uses
- Used in the management of hypocalcemia when prescribed
- May be prescribed for renal osteodystrophy
- Used in certain cases of osteomalacia and rickets
- May be prescribed for Vitamin D-related disorders affecting calcium and bone metabolism
- Supports appropriate calcium and phosphate utilization under medical supervision
Benefits
- Contains Alfacalcidol, an active Vitamin D analogue
- Helps regulate calcium and phosphate metabolism
- Supports normal bone mineralization
- Helps improve calcium availability when prescribed for specific deficiencies or disorders
- Convenient tablet formulation
Possible Side Effects
Possible side effects are mainly associated with excessive calcium levels and may include:
- Nausea or vomiting
- Constipation
- Abdominal discomfort
- Increased thirst
- Increased urination
- Weakness or fatigue
- Headache
Excessive calcium levels can become serious. Seek medical attention if severe weakness, persistent vomiting, confusion, abnormal heartbeat or other concerning symptoms occur.
Pharmacist Advice
Take BONE LIFT only according to your doctor's prescribed dose. Alfacalcidol therapy may require monitoring of blood calcium and other laboratory parameters.
Do not take additional Vitamin D or calcium supplements without informing your doctor, as excessive Vitamin D activity can increase the risk of hypercalcemia.
Tell your doctor if you have kidney disease, a history of kidney stones, high blood calcium levels or other calcium-metabolism disorders.
Inform your doctor or pharmacist about all medicines and supplements you are taking.